Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Dennis Dietrich
mi
from
Great Falls, MT
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Dennis Dietrich
mi
from
Great Falls, MT
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
University of Medicine and Dentistry of New Jersey School of Neurology
mi
from
Stratford, NJ
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
University of Medicine and Dentistry of New Jersey School of Neurology
mi
from
Stratford, NJ
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Upstate Clinical Research LLC 3
mi
from
Albany, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Upstate Clinical Research LLC 3
mi
from
Albany, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Neurological Specialists of Long Island
mi
from
Great Neck, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Neurological Specialists of Long Island
mi
from
Great Neck, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Multiple Sclerosis Center of Northeastern NY
mi
from
New York, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Multiple Sclerosis Center of Northeastern NY
mi
from
New York, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Comprehensive MS Care Clinic at South Shore Multiple Sclerosis
mi
from
Patchogue, NY
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Comprehensive MS Care Clinic at South Shore Multiple Sclerosis
mi
from
Patchogue, NY
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Meritcare Neuroscience Center Neurology
mi
from
Fargo, ND
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Meritcare Neuroscience Center Neurology
mi
from
Fargo, ND
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
University of Cincinnati
mi
from
Cincinnati, OH
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
MS Center of Oklahoma
mi
from
Oklahoma City, OK
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
MS Center of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Neurology and Sleep Medicine
mi
from
Bethlehem, PA
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Neurology and Sleep Medicine
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Swedish Medical Center - Cherry Hill
mi
from
Seattle, WA
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Swedish Medical Center - Cherry Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Neurology & Neurological Association of Tacoma
mi
from
Tacoma, WA
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Neurology & Neurological Association of Tacoma
mi
from
Tacoma, WA
Click here to add this to my saved trials
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated:  9/5/2017
Instituto Medico Rodriguez Alfici
mi
from
Godoy Cruz,
Oral Cladribine in Early Multiple Sclerosis (MS)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
Status: Enrolling
Updated: 9/5/2017
Instituto Medico Rodriguez Alfici
mi
from
Godoy Cruz,
Click here to add this to my saved trials
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated:  9/22/2017
University of Chicago
mi
from
Chicago, IL
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated: 9/22/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated:  10/3/2017
Stony Brook Univeristy
mi
from
Stony Brook, NY
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated: 10/3/2017
Stony Brook Univeristy
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Electric Stimulation of the Eye to Improve Vision After Trauma
Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma
Status: Enrolling
Updated:  11/1/2017
Wills Eye Hospital
mi
from
Philadelphia, PA
Electric Stimulation of the Eye to Improve Vision After Trauma
Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma
Status: Enrolling
Updated: 11/1/2017
Wills Eye Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Status: Enrolling
Updated:  11/2/2017
University of Colorado
mi
from
Boulder, CO
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
Status: Enrolling
Updated: 11/2/2017
University of Colorado
mi
from
Boulder, CO
Click here to add this to my saved trials
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated:  11/9/2017
University of Texas at Austin
mi
from
Austin, TX
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated: 11/9/2017
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
mi
from
San Francisco, CA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
mi
from
Torrance, CA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigator Site
mi
from
Iowa City, IA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigator Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis
mi
from
Baltimore, MD
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
Novartis Investigative Site
mi
from
Camperdown,
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
Camperdown,
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington Medicine MS Center
mi
from
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington Medicine MS Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated:  12/4/2017
University of Washington, Health Sciences Building
mi
from
Seattle, WA
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/4/2017
University of Washington, Health Sciences Building
mi
from
Seattle, WA
Click here to add this to my saved trials
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
Single Center, Randomized, Open Label Study in Relapsing MS Patients on PLEGRIDY to Assess Topical Application of Preparation H (Phenylephrine) on Mitigation of Erythema Severity and Size.
Status: Enrolling
Updated:  12/18/2017
New York University School of Medicine
mi
from
New York, NY
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
Single Center, Randomized, Open Label Study in Relapsing MS Patients on PLEGRIDY to Assess Topical Application of Preparation H (Phenylephrine) on Mitigation of Erythema Severity and Size.
Status: Enrolling
Updated: 12/18/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
MS Symptom Management Study
Enhancing the Benefits of Pain and Fatigue Treatment in MS
Status: Enrolling
Updated:  12/21/2017
University of Washington, Ninth and Jefferson Building
mi
from
Seattle, WA
MS Symptom Management Study
Enhancing the Benefits of Pain and Fatigue Treatment in MS
Status: Enrolling
Updated: 12/21/2017
University of Washington, Ninth and Jefferson Building
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Vaporized Marijuana on Neuropathic Pain
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated:  1/11/2018
CTSC Clinical Research Center, Sacramento VA Medical Center
mi
from
Sacramento, CA
Effects of Vaporized Marijuana on Neuropathic Pain
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated: 1/11/2018
CTSC Clinical Research Center, Sacramento VA Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Stanford University
mi
from
Stanford, CA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
mi
from
Aurora, CO
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Shepherd Center
mi
from
Atlanta, GA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Johns Hopkins
mi
from
Baltimore, MD
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Beth Israel Deaconess
mi
from
Boston, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Beth Israel Deaconess
mi
from
Boston, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Multiple Sclerosis Research Center of New York
mi
from
New York, NY
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Multiple Sclerosis Research Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Ohio State University
mi
from
Columbus, OH
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
Status: Enrolling
Updated:  1/13/2018
Department of Health and Exercise Science
mi
from
Fort Collins, CO
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
Status: Enrolling
Updated: 1/13/2018
Department of Health and Exercise Science
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
Status: Enrolling
Updated:  1/25/2018
EMD Serono, Inc.
mi
from
Rockland, MA
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
Status: Enrolling
Updated: 1/25/2018
EMD Serono, Inc.
mi
from
Rockland, MA
Click here to add this to my saved trials
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2018
MS Center at Evergreen Health
mi
from
Kirkland, WA
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2018
MS Center at Evergreen Health
mi
from
Kirkland, WA
Click here to add this to my saved trials
Methylphenidate to Improve Balance and Walking in MS
Methylphenidate to Improve Balance and Walking in MS
Status: Enrolling
Updated:  3/8/2018
Portland VA Medical Center
mi
from
Portland, OR
Methylphenidate to Improve Balance and Walking in MS
Methylphenidate to Improve Balance and Walking in MS
Status: Enrolling
Updated: 3/8/2018
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated:  3/8/2018
LSU Health Sciences Center - Shreveport
mi
from
Shreveport, LA
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated: 3/8/2018
LSU Health Sciences Center - Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
Pilot Study of Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications (OUCH)
Status: Enrolling
Updated:  3/14/2018
MS Center at Evergreen Health
mi
from
Kirkland, WA
Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
Pilot Study of Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications (OUCH)
Status: Enrolling
Updated: 3/14/2018
MS Center at Evergreen Health
mi
from
Kirkland, WA
Click here to add this to my saved trials
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  3/15/2018
Tisch MS Research Center of New York
mi
from
New York, NY
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 3/15/2018
Tisch MS Research Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Click here to add this to my saved trials